Search

Katarzyna M Urbanska

from Philadelphia, PA
Get Report
Also known as:
Katarzyna Urbanska
Connected to:
Adam Urbanski, 78Alison T Urbanski, 29Andrea Urbanski, 63Anthony S Urbanski, 85Cheryl D Urbanski, 73Craig E Urbansky, 43David M Urbanski, 70Eileen P Urbanski, 70Elizabeth A Urbanski, 56Greg A Urbanski, 62

Katarzyna Urbanska Phones & Addresses

  • Philadelphia, PA

Resumes

Resumes

Katarzyna Urbanska Photo 1

Director, Business Development, Search And Evaluation, Cell Therapy, Business Development Transactions

View page
Location:
Philadelphia, PA
Industry:
Pharmaceuticals
Work:
University of Pennsylvania - Greater Philadelphia Area since 2010
Postdoctoral Research Associate
Education:
Temple University - Lewis Katz School of Medicine 2005 - 2008
Jagiellonian University
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry
Skills:
Molecular Biology
Cell Culture
Cell
Cell Biology
Cancer
Immunohistochemistry
Assay Development
In Vitro
Pcr
Clinical Research
Western Blotting
Rt Pcr
Biochemistry
Polymerase Chain Reaction
Cancer Immunotherapy
Immunofluorescence
Flow Cytometry
Immunology
Science
Tumor Immunology
Molecular and Cellular Biology
Translational Science
Elisa
Reverse Transcription Polymerase Chain Reaction
Molecular Immunology
Molecular Cloning
Katarzyna Urbanska Photo 2

Katarzyna Urbanska

View page

Publications

Us Patents

Methods And Compositions Of A Follicle Stimulating Hormone Receptor Immunoreceptor Or Chimeric Antigen Receptor

View page
US Patent:
20200199191, Jun 25, 2020
Filed:
Jan 3, 2020
Appl. No.:
16/733670
Inventors:
- Philadelphia PA, US
Caitlin Stashwick - Philadelphia PA, US
Katarzyna Urbanska - Philadelphia PA, US
International Classification:
C07K 14/59
A61K 38/00
C07K 14/725
Abstract:
The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).

Universal Immune Receptor Expressed By T Cells For The Targeting Of Diverse And Multiple Antigens

View page
US Patent:
20190330300, Oct 31, 2019
Filed:
Mar 11, 2019
Appl. No.:
16/298310
Inventors:
- Philadelphia PA, US
Katarzyna Urbanska - Philadelphia PA, US
Daniel J. Powell - Bala Cynwyd PA, US
International Classification:
C07K 14/725
C12N 15/85
C07K 14/705
C07K 14/465
A61K 47/68
Abstract:
The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.

Methods And Compositions Of A Follicle Stimulating Hormone Receptor Immunoreceptor Or Chimeric Antigen Receptor

View page
US Patent:
20180057557, Mar 1, 2018
Filed:
Nov 3, 2015
Appl. No.:
15/524158
Inventors:
- Philadelphia PA, US
Caitlin Stashwick - Philadelphia PA, US
Katarzyna Urbanska - Philadelphia PA, US
International Classification:
C07K 14/59
C07K 14/725
Abstract:
The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).

Universal Immune Receptor Expressed By T Cells For The Targeting Of Diverse And Multiple Antigens

View page
US Patent:
20170342124, Nov 30, 2017
Filed:
May 10, 2017
Appl. No.:
15/591910
Inventors:
- Philadelphia PA, US
Katarzyna Urbanska - Philadelphia PA, US
International Classification:
C07K 14/725
A61K 47/68
C12N 15/85
C07K 14/465
C07K 14/705
Abstract:
The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.

Universal Immune Receptor Expressed By T Cells For The Targeting Of Diverse And Multiple Antigens

View page
US Patent:
20140234348, Aug 21, 2014
Filed:
Sep 24, 2012
Appl. No.:
14/346612
Inventors:
- Philadelphia PA, US
Katarzyna Urbanska - Philadelphia PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
C07K 14/725
C12N 15/85
C07K 14/705
A61K 47/48
C07K 14/465
US Classification:
4241841, 536 235, 530350, 435325, 4353201
Abstract:
The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
Control profile
Katarzyna M Urbanska from Philadelphia, PA Get Report